Related Articles
HLA class I antigen and transporter associated with antigen processing downregulation in metastatic lesions of head and neck squamous cell carcinoma as a marker of poor prognosis
Characterization of cytomegalovirus pp65-HLA-A24 peptide-specific CTL lines from metastatic melanoma patients
Dendritic cell-based vaccination in metastatic melanoma patients: Phase II clinical trial
HLA-G as a target molecule in specific immunotherapy against renal cell carcinoma
Capability of SART3109-118 peptide to induce cytotoxic T lymphocytes from prostate cancer patients with HLA class I-A11, -A31 and -A33 alleles